Abstract
Background. Arm pain is common, costly to health services and society. Physiotherapy referral is standard management, and while awaiting treatment, advice is often given to rest, but the evidence base is weak.
Objective. To assess the cost-effectiveness of advice to remain active (AA) vs advice to rest (AR); and immediate physiotherapy (IP) vs usual care (waiting-list) physiotherapy (UCP).
Methods. Twenty-six-week within-trial economic evaluation (538 participants aged ≥18 years randomised to usual care i.e. AA(n=178), AR(n=182) or IP(n=178)). Regression analysis estimated differences in mean costs and Quality Adjusted Life Years (QALYs). Incremental cost-effectiveness ratios (ICERs) and cost-effectiveness acceptability curves were generated. Primary analysis comprised the 193 patients with complete resource use (UK NHS perspective) and EQ-5D data. Sensitivity analysis investigated uncertainty.
Results. Baseline-adjusted cost differences were £88[95%CI:-14,201]) AA vs AR; -£14[95%CI:-87,66]) IP vs UCP. Baseline adjusted QALY differences were 0.0095[95% CI:-0.0140,0.0344]) AA vs AR; 0.0143[95%CI:-0.0077,0.0354]) IP vs UCP. There was a 71 % and 89% probability that AA (vs AR) and IP (vs UCP) were the most cost-effective option using a threshold of £20,000 per additional QALY. The results were robust in the sensitivity analysis.
Conclusion. The difference in mean costs and mean QALYs between the competing strategies was small and not statistically significant. However, decision-makers may judge that IP was not shown to be any more effective than delayed treatment, and was no more costly than delayed physiotherapy. AA is preferable to one that encourages AR, as it is more effective and more likely to be cost-effective than AR.
Objective. To assess the cost-effectiveness of advice to remain active (AA) vs advice to rest (AR); and immediate physiotherapy (IP) vs usual care (waiting-list) physiotherapy (UCP).
Methods. Twenty-six-week within-trial economic evaluation (538 participants aged ≥18 years randomised to usual care i.e. AA(n=178), AR(n=182) or IP(n=178)). Regression analysis estimated differences in mean costs and Quality Adjusted Life Years (QALYs). Incremental cost-effectiveness ratios (ICERs) and cost-effectiveness acceptability curves were generated. Primary analysis comprised the 193 patients with complete resource use (UK NHS perspective) and EQ-5D data. Sensitivity analysis investigated uncertainty.
Results. Baseline-adjusted cost differences were £88[95%CI:-14,201]) AA vs AR; -£14[95%CI:-87,66]) IP vs UCP. Baseline adjusted QALY differences were 0.0095[95% CI:-0.0140,0.0344]) AA vs AR; 0.0143[95%CI:-0.0077,0.0354]) IP vs UCP. There was a 71 % and 89% probability that AA (vs AR) and IP (vs UCP) were the most cost-effective option using a threshold of £20,000 per additional QALY. The results were robust in the sensitivity analysis.
Conclusion. The difference in mean costs and mean QALYs between the competing strategies was small and not statistically significant. However, decision-makers may judge that IP was not shown to be any more effective than delayed treatment, and was no more costly than delayed physiotherapy. AA is preferable to one that encourages AR, as it is more effective and more likely to be cost-effective than AR.
Original language | English |
---|---|
Pages (from-to) | 179-186 |
Number of pages | 8 |
Journal | Family Practice |
Volume | 36 |
Issue number | 2 |
Early online date | 6 Jun 2018 |
DOIs | |
Publication status | Published - Apr 2019 |
Bibliographical note
Funding: Arthritis Research UK (Clinical Studies Grant, reference: 19231)Clinical trial registration: www.controlled-trials.com, reference: ISRCTN 79085082
Ethical approval: UK South Central (Hampshire A) Research Ethics Committee, reference: 11/SC/0107.
Acknowledgements
Prof. Kim Burton has been involved in the development of The Arm Book (ISBN: 978-0117069145), to which the experimental leaflet in this trial is related, and may receive future royalties on the booklet.
Keywords
- arm pain
- physiotherapy
- economic evaluation
- cost-effectiveness
- trial
- QALYs
- Arm pain
- THERAPY
- LOW-BACK-PAIN
Fingerprint
Dive into the research topics of 'Cost-utility of maintained physical activity and physiotherapy in the management of distal arm pain: an economic evaluation of data from a randomised controlled trial'. Together they form a unique fingerprint.Profiles
-
Gareth Jones
- School of Medicine, Medical Sciences & Nutrition, Applied Health Sciences - Professor in Epidemiology
- School of Medicine, Medical Sciences & Nutrition, MRC/Versus Arthritis Centre for Musculoskeletal Health and Work
- Institute of Applied Health Sciences
- School of Medicine, Medical Sciences & Nutrition, Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH)
- School of Medicine, Medical Sciences & Nutrition, Epidemiology Group
Person: Academic
-
Gary Macfarlane
- School of Medicine, Medical Sciences & Nutrition, Applied Health Sciences - Clinical Chair in Epidemiology
- School of Medicine, Medical Sciences & Nutrition, MRC/Versus Arthritis Centre for Musculoskeletal Health and Work
- School of Medicine, Medical Sciences & Nutrition, Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH)
- School of Medicine, Medical Sciences & Nutrition, Epidemiology Group
Person: Clinical Academic
-
Paul McNamee
Person: Academic